This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2005-2014.
Location History:
- Middletown, CT (US) (2005)
- Wallingford, CT (US) (2005 - 2008)
- Cheshire, CT (US) (2012)
- Phoenixville, PA (US) (2013 - 2014)
Company Filing History:
Years Active: 2005-2014
Title: Xuejie Yang: Innovator in Antiviral Compounds
Introduction
Xuejie Yang is a prominent inventor based in Wallingford, CT (US). He has made significant contributions to the field of antiviral research, particularly in the development of compounds targeting the Hepatitis C virus. With a total of six patents to his name, Yang's work is crucial in the ongoing fight against viral infections.
Latest Patents
Yang's latest patents focus on Hepatitis C virus inhibitors. The present disclosures are generally directed to antiviral compounds, specifically aimed at inhibiting the function of the NS5A protein encoded by the Hepatitis C virus (HCV). These patents include compositions comprising such compounds and methods for effectively inhibiting the function of the NS5A protein.
Career Highlights
Xuejie Yang has established a successful career at Bristol-Myers Squibb Company, where he has been instrumental in advancing antiviral research. His innovative approaches and dedication to scientific discovery have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Yang has collaborated with notable coworkers, including Yuping Qiu and Makonen Belema. These partnerships have fostered a collaborative environment that enhances the research and development of antiviral therapies.
Conclusion
Xuejie Yang's contributions to antiviral research, particularly in the development of Hepatitis C virus inhibitors, highlight his importance as an inventor in the pharmaceutical field. His work continues to pave the way for advancements in the treatment of viral infections.
